Member Info for BOJO2020

WW,

My thoughts: these chips ain't getting much cheaper!

ATB

Thanks Mia. I have noticed quite a few mentions on Proactive. Owing to both Scancell commercial department and Proactive getting their act together I am guessing? Several stories and links to ensure people are well read on Scancell’s latest. Anybody spending a little time on proactive are likely to come across these news. Makes me wonder if Scancell have an option to build and boost a profile?

Troajan thanks.

2nd article

https://www.proactiveinvestors.co.uk/companies/news/220600/scancell-focuses-on-development-of-two-critical-cancer-fighting-assets-220600.html

Sorry if previously posted it has this morning’s stamp on it

Https://angleplc.com/onc-adapt-laboratories/

Assay development…

Hard to be entirely sure what this means in terms of physical sales but PD-L1 looks interesting.

Should this, will this be RNS’d

Keep an eye on this page

LL

Don’t think so. I think Scancell have been wrong footed by the Auditors delay. They likely have a tight time schedule. Originally planning AGM, Investors Meet and not forgetting presentations. We may have to wait a little for them to make time in a busy schedule is my guess. No drama

Or share holders and in this case it’s as plain as the nose on your face!

Paul Brains,

Having good knowledge about everything rather than an absolute knowledge about one particular facet is where it is at imo. That is not to say that one with an expert knowledge cannot have a general understanding of business and investing. I guess that is why Lindy employs people with so many separate disciplines. I am sure she recognises it is not practical, possible or even required to be an expert at everything...

Well what ever the reason is. What is the point in guessing? Really can not believe it. News issued straight from the horses mouth and it is already being interpreted to 'possible other meanings...' What are people going to make of the actual results? An alien invasion perhaps.

Yes,

OBD flew following raise and previous outstanding results for test. All be it a delayed reaction...

Seem to remember a lot of holders there were jumping into rabbit holes and confusing themselves and others. Hate to think people here are influenced by others. If ever there was an example of making ones own mind up it was OBD.

Yes RP,

As I have said twice today. A collaboration yes but a straight buy out which the others are eluding too. Just fanciful and baseless. I count that as a shortcut which given what we are invested in is unrealistic. Roll on 24th so people can get a much needed reset and focus on the facts. After all we should expect many positives.

EE, WTP, Moonparty,

Think of clinical trials like this. If you asked most people to jump over a line drawn on the floor they would achieve this. Ask them to jump over a line at a height of one meter and very many would achieve this. A line of two meters or more what then? How many would still be left in the game? So if you are Pharma and you are watching the jumping game would you sign people up who jumped the line on the floor (everyone) or one meter or wait for the few that could jump two meters? So this is the exact opposite of FOMO. However, if they were interested but cautious they could announce a collaboration and a buyout eventually as i said before.

I do like the look of SCOPE.

ATB

Hi EE,

I think Chester is reading this correctly. In order for the value of a novel drug to be realised Scancell need to prove them beyond any reasonable doubt over time. I am afraid that there is no shortcut but that does not mean there is no monetary value in this; whilst there may be trading opportunities as results are released, deals will come towards the end when Scancell have done all the donkey work.

Remember what Scancell are doing here: proving the utility and long term benefit of novel drugs. That is the game for Scancell and it is the same game for all pharma big or small. So if big pharma know the game why would they jump in early days? A collaboration yes, a buyout eventually.

ATB

Stephen not daft. Nice 45p in the sky rocket

Only news required is funding and this will do 50 to 100% even if diluted imo

CW,

Sometimes I do not think it would matter what you post as some people are just going to react in the same way. Like a jerk reaction. I do not think you need explain yourself to anybody. Just carry on posting and people will see the merits or not.

ATB.

If you were pharma and watching a trial in progress with positive interim data surely you would wait until the trial had concluded. I just don’t see pharma doing FOMO or jumping the gun.

Bantham,

The aim of translational research is to move promising scientific discoveries into actual treatments that benefit patients. Just my opinion but this is exactly where Parsortix is at. You can put your own spin on it of course.

For those that have a medium to long term outlook. IMO

Ruck,

Your 10.06. Why do I have flashbacks to Hansel & Gretel when reading your post? You do know that the Witch did get pushed into her own oven and died before she could fatten up and eat her victims.

Or have I got the wrong end of the stick again :)

The beauty of any question is that when answered it usually is helpful none the less. So re delivery method I doubt a private investor would think to ask that or at least not be the first question. I do agree though that analysts should have done their research, if anything sounded a bit lazy to me. But the net situation is that all people tuning into Scancell for the first time not only can see excellent results but also appreciate that they use an excellent delivery method. Maybe that analyst was a SCLP fan in disguise and was acting daft? Was it Panmure? They know us very well.